Our study describes strategies for molecular intervention involving the cellular interaction of stromal cells (POSTN+ fibroblasts) with immune components (SPP1+ macrophages), and suggests treatment decision-making for primary and recurrent tumors, which might ultimately improve survival in HNSCC patients. This evidence concerns the gene SPP1 and head and neck squamous cell carcinoma.